Figure 1From: Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling Comparison serum profiles time course. Top 8 differential peaks that exhibit changes over the three time points: pre-treatment (PreTx) (red), after two cycles of treatment (Post-2) (blue), and at end of treatment (EOT) (green). Eight peaks randomly selected out of the remaining 638 peaks. Each overlay contains spectra with normalized intensities.Back to article page